Anticlastogenic effect of Vitamin C on cisplatin induced chromosome aberrations in human lymphocyte cultures

Mutation Research - Genetic Toxicology and Environmental Mutagenesis

Volumn 498, Issue 1-2, 2001, Pages 89-98

  Nefic, Hilada ^a  

^a Faculty of Science Sarajevo   (Bosnia and Herzegovina)

Author keywords

Anticlastogen; Chromosomal aberrations; Cisplatin; Vitamin C

Indexed keywords

ANTIMUTAGENIC AGENT; ANTIOXIDANT; ASCORBIC ACID; CELL DNA; CISPLATIN; SCAVENGER;

ANEUPLOIDY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL PROTECTION; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; GENETIC DAMAGE; HUMAN; HUMAN CELL; LYMPHOCYTE CULTURE; MACROMOLECULE; METAPHASE CHROMOSOME; MITOSIS INDEX; OXIDATIVE STRESS; PRIORITY JOURNAL;

ANEUPLOIDY; ANTIOXIDANTS; ASCORBIC ACID; CELLS, CULTURED; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; CISPLATIN; CYTOGENETIC ANALYSIS; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; LYMPHOCYTES; MITOTIC INDEX; MUTAGENS;

EID: 0035889596     PISSN: 13835718     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1383-5718(01)00269-8     Document Type: Article

References (59)

1. Genetic toxicology of ascorbic acid
2. Inhibitors of mutagenesis and their relevance to carcinogenesis. Report by ICPEMC expert group on antimutagens and desmutagens
3. Antioxidant defenses against reactive oxygen species causing genetic and other damage
4. Enhancement of the chromosome-damaging action of ascorbate by transition metals
5. Vitamin C is positive in the DNA synthesis inhibition and sister-chromatid exchange tests
6. The SCE-inducing capacity of Vitamin C: Investigations in vitro and in vivo
7. Mutagenic activity of ascorbate in mammalian cell cultures
8. Studies on the mutagenic activity of ascorbic acid in vitro and in vivo
9. On the cytotoxicity of Vitamin C and metal ions
10. Cisplatin generates superoxide anion by interaction with DNA in a cell-free system
11. Mutagenicity, cytotoxicity and DNA crosslinking in V79 Chinese hamster cells treated with cis- and trans-Pt(II) diamminedichloride
12. Mutagenicity and genotoxicity of the major DNA adduct of the antitumor drug cis-diamminedichloroplatinum(II)
13. Effects of DNA adduct structure and distribution on the mutagenicity and genotoxicity of two platinum anticancer drugs
14. Interlaboratory validation of a new assay for DNA-protein cross-links
15. Patterns of second malignant neoplasms in children
16. Mutagenic activity of anticancer agent cis-dichlorodiammine platinum-II
17. Citogeneticka analiza genotoksicnog djelovanja cisplatina na humane limfocite in vitro
18. Increased frequency of chromosomal damage in peripheral blood lymphocytes up to nine years following curative chemotherapy of patients with testicular carcinoma
19. Relationships between sister-chromatid exchange and mutagenicity, toxicity and DNA damage
20. Genotoxicity of platinum and palladium compounds in human and bacterial cells
21. Effect of preinduction of metallothionein synthesis on clastogenicity of anticancer drugs in mice
22. Modulation of cyclophosphamide mutagenicity by Vitamin C in the in vivo rodent micronucleus assay
23. Effects of high doses of Vitamins C and E against doxorubicin-induced chromosomal damage in Wistar rat bone marrow cells
24. Effect of selected antimutagens on the genotoxicity of antitumour agents
25. Vitamins C and E and cancer
26. Ascorbic acid and β-carotene as modulators of oxidative damage
27. Ascorbic acid and 6-deoxy-6-chloro-ascorbic acid: Potential anticancer drugs
28. Chromosome preparations of leukocytes cultured from human peripheral blood
29. Protection and induction of chromosomal damage by Vitamin C in human lymphocyte cultures
30. Vitamin C medited protection on cisplatin-induced mutagenicity in mice
31. Anticlastogenic effect of Vitamin C on cisplatin in vivo
32. Effects of the antioxidants curcumin and Vitamin C on cisplatin-induced clastogenesis in Wistar rat bone marrow cells
33. The action of antimutagens on chemically induced SCE
34. The action of anticlastogens in human lymphocyte cultures and their modification by rat-liver S9 mix. Part II. Studies with Vitamins C and E
35. Co-administration of ascorbic acid with cyclophosphamide (CPA) to pregnant mice inhibits the clastogenic activity of CPA in preimplantation murine blastocyts
36. Modulation of cyclophosphamide mutagenicity by Vitamin C in the in vivo rodent micronucleus assay
37. Vitamin C intake influences the bleomycin-induced chromosome damage assay: Implications for detection of cancer susceptibility and chromosome breakage syndromes
38. The effect of antioxidants on bleomycin treatment in vitro and in vivo genotoxicity assays
39. The effect of various antioxidants and other modifying agents on oxygen-radical-generated DNA damage in human lymphocytes in the COMET assay
40. Effect of oxidants and antioxidants on chromosomal breakage in Fanconi anemia lymphocytes
41. Antimutagenic mechanism of Vitamin C and its derivatives in mammalian cells in culture
42. Antimutagenic activity of vitamins in cultured mammalian cells
43. Effects of L-ascorbic acid on the mutagenicity of ethyl methanesulfonate in cultured mammalian cells
44. Effects of l-ascorbic acid on the clastogenicity of catecholamines
45. Antimutagenic efficacy of higher doses of Vitamin C
46. Inhibition of cyclophosphamide and mitomycin C-induced sister chromatid exchanges in mice by Vitamin C
47. Enhancement and attenuation of cytogenetic damage by Vitamin C in cultured human lymphocytes exposed to Thiotepa or L-ethionine
48. The effect of Vitamin C on oxygen radical-induced sister chromatid exchanges
49. Protective effects of α-hederin, chlorophillin and ascorbic acid towards the induction of micronuclei by doxorubicin in cultured human lymphocytes
50. 1-induced mutagenesis in Salmonella typhimurium TA98 and TA100
51. Antioxidants reduce the mutagenic effect of malonaldehyde and β-propiolactone. Part IX. Antioxidants and cancer
52. Tetracycline induced mutation in cultured Chinese hamster cells
53. Ascorbic acid (Vitamin C) improves the antineoplastic activity of doxorubicin, cisplatin, and paclitaxel in human breast carcinoma cells in vitro
54. Biological nature of the effect of ascorbic acids on the growth of human leukemic cells
55. Effect of Vitamins A, C and glutathione on the mutagenicity of benzo[a]pyrene mediated by S9 from Vitamin A-deficient rats
56. Vitamins as antimutagens: Advantages and some possible mechanisms of antimutagenic action
57. Antioxidant supplementation decreases oxidative DNA damage in human lymphocytes
58. Effect of ascorbic acid prophylaxis on the frequency of chromosome aberrations, urine mutagenicity and nucleolus test in workers occupationally exposed cytostatic drugs
59. Anticlastogenicity in cultured mammalian cells